A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 39/00 (2006.01) A61P 9/10 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2717071
Disclosed herein, in certain embodiments, is a method for treating an inflammatory disorder. In some embodi-ments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF--activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof.
L'invention concerne, dans certains modes de réalisation, un procédé permettant de traiter un trouble inflammatoire. Dans un certain nombre de modes de réalisation, le procédé consiste à administrer un agent actif qui inhibe (i) la liaison de MIF à CXCR2 et CXCR4 et/ou (ii) l'activation de MIF de CXCR2 et CXCR4; (iii) l'aptitude de MIF à former un homomultimère; ou une combinaison de ceux-ci.
Bernhagen Juergen
Schultz Joshua Robert
Vollrath Benedikt
Weber Christian
Zernecke Alma
Carolus Therapeutics Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Methods of treatment using anti-mif antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment using anti-mif antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using anti-mif antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1684000